Cargando…
NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain
The development of nitric oxide (NO)- and hydrogen sulfide (H(2)S)-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) has generated more potent anti-inflammatory drugs with increased safety profiles. A new hybrid molecule incorporating both NO and H(2)S donors into aspirin (NOSH-aspirin) was re...
Autores principales: | Fonseca, Miriam D, Cunha, Fernando Q, Kashfi, Khosrow, Cunha, Thiago M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492749/ https://www.ncbi.nlm.nih.gov/pubmed/26236481 http://dx.doi.org/10.1002/prp2.133 |
Ejemplares similares
-
Exploring the Potential of Nitric Oxide and Hydrogen Sulfide (NOSH)-Releasing Synthetic Compounds as Novel Priming Agents against Drought Stress in Medicago sativa Plants
por: Antoniou, Chrystalla, et al.
Publicado: (2020) -
NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties
por: Kashfi, Khosrow, et al.
Publicado: (2015) -
Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling()
por: Vannini, Federica, et al.
Publicado: (2015) -
Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐ and H(2)S‐releasing hybrid
por: Chattopadhyay, Mitali, et al.
Publicado: (2016) -
NOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia Polarization
por: Ji, Jing, et al.
Publicado: (2017)